Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets

Journal of Infection

Volumn 65, Issue 1, 2012, Pages 1-16

  Denizot, M ^a   Neal, J W ^b   Gasque, P ^a  

^a University of La Reunion   (Reunion)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Glia; Innate immune system; Interferon; Pattern recognition receptors; RNAi; Virus

Indexed keywords

CD209 ANTIGEN; CHEMOKINE; ENFUVIRTIDE; MANNOSE MACROPHAGE RECEPTOR; NONSTRUCTURAL PROTEIN 1; NUCLEIC ACID; P SELECTIN GLYCOPROTEIN LIGAND 1; PATTERN RECOGNITION RECEPTOR; PROTEIN 3C; PROTEIN MDA 5; PROTEIN VP24; PROTEIN VP35; RETINOIC ACID INDUCIBLE PROTEIN I; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR B; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; VIRUS E PROTEIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ALPHA VIRUS; ANTIVIRAL ACTIVITY; APOPTOSIS; AVIATION; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; CHIKUNGUNYA ALPHAVIRUS; CLIMATE CHANGE; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG DEGRADATION; DRUG PENETRATION; DRUG TRANSPORT; EBOLA VIRUS; ENTEROVIRUS; ENTEROVIRUS 71; FLAVIVIRUS; GENE EXPRESSION; GENE SILENCING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOSURVEILLANCE; INFECTION RISK; INFLUENZA VIRUS A; INNATE IMMUNITY; JAPANESE ENCEPHALITIS VIRUS; NERVE FIBER TRANSPORT; NEUROPATHOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PARAMYXOVIRUS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RABIES; RABIES VIRUS; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE INJURY; URBANIZATION; VIRAL CLEARANCE; VIRUS DETECTION; VIRUS ENCEPHALITIS; VIRUS ENTRY; VIRUS INHIBITION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM; COMMUNICABLE DISEASES, EMERGING; ENCEPHALITIS, VIRAL; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; VIRUSES;

EID: 84861483955     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.03.019     Document Type: Review

References (168)

1. Tyler K. Emerging infections of the central nervous system: part1. Arch Neurology 2009, 66(8):1-18.
2. Tyler K. Emerging infections of the central nervous system: part2. Arch Neurology 2009, 66.
3. Davis L.E., Beckman J.D., Tyler K.L. North American encephalitic arbroviruses. Neurol Clin 2008, 236(3):727-747.
4. Misra K.M., Kalita J. Overview: Japanese encephalitis. Prog Neurobiol 2010, 91:108-120.
5. Charrel R.N., de Lamballerie X., Raoult D. Chikungunya out breaks - the globalization of vector bourn disease. N Eng J Med 2007, 356:769-771.
6. Wong K.T. Emerging epidemic viral encephalitis with a special focus on henipavirus. Acta Neuropath 2010, 120(3):317-325.
7. Powers A.M., Logue C.H. Changing patterns of Chikungunya virus; re emergence of a zoonotic arbrovirus. J Gen Vrol 2007, 88:2363-2377.
8. Hsu V.P., Hossain M., Parashar U.D., Monsur Ali M., Ksiazek T.G., Kuzmin I., et al. Nipah virus encephalitis re-emergence, in Bangladesh. Emerg Infec Dis 2004, 10:12.
9. Horimoto T., Kawaoka Y. Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 2001, 14:129-149.
10. Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis and management of enterovirus 71. Lancet Neurol 2010, 11:1097-1105.
11. Tordo N., Bahloul C., Jacob Y.L., Jallet C., Perin P., Badrane H., et al. Rabies: epidemiological tendencies and control tools. Dev Biol Basel 2006, 125:3-13.
12. Bwaka M.A., Bonnet M.J., Calain P., Colebunders R., DeRoo A., Guimard Y., et al. Ebola haemorrhagic fever in Kikwit Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999, 179(Suppl. 1):S1-S7.
13. Savarin C., Bergmann C.C. Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms. Curr Opin Pharmacol 2008, 8(4):472-479.
14. Hauwel M., Furon E., Canova C., Griffiths M.R., Neal J.W., Gasque P. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res Brain Res Rev 2005, 48:220-233.
15. Griffin D.E. Immune response to RNA - virus infections of the CNS. Nat Rev Immunol 2003, 3:493-502.
16. Abbot N.J. Morphology of non mammalian glial cells; functional implications. Neuroglia 1995, Chapter 4, Oxford University Press. H. Kettleman, B.R. Ransom (Eds.).
17. Lowenstein P.R. Immunology of viral-vector-mediated gene transfer into the brain: an evolutionary developmental perspective. Trends Immunol 2002, 23:23-30.
18. Pachter J.S., de Vries H.E., Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 2003, 62:593-604.
19. Weller R.O. Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease prion disorders and multiple sclerosis. J Neuropath Exp Neurology 1998, 885-894.
20. Martin G., Furlan R., Comi G., Adorini L. The ependymal route to the CNS: an emerging gene-therapy approach for MS. Trends Immunol 2001, 22(9):483-490.
21. McMenamin P.G. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater leptomeninges, and choroid plexus of the rat brain as demonstrated in whole mount preparations. J Comp Neurol 1999, 405:553-562.
22. Canova C., Neal J.W., Gasque P. Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis. J Neuro inflammation 2006, 3:22.
23. Rivest S. Regulation of innate of immune responses in the brain. Nat Rev Immunol 2009, 9:429-439.
24. Gyure K.A. West Nile infections. J Neuropath Exp Neurol 2009, 68(10):1053-1060.
25. Mackenzie J.S., Field H.E. Emerging encephalitogenic viruses: lyssavirus and hepaviruses transmitted by frugivorous bats. Arch Virol 2004, 18:97-111.
26. Maisner A., Neufeld J., Weingart I.H. Organ -and endothelial tropism of Nipah virus infections in vivo and in vitro. Thromb Haemost 2009, 102(6):1014-1023.
27. Lee B. Envelope -receptor interactions with Nipah virus patholobiology. Ann NY Acad Sci 2007, 1102:51-65.
28. Verma S., Lo Y., Chapagain M., Lum S., Kumar M., Gurjav U., et al. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules; transmigration across the in vitro blood brain barrier. Virology 2009, 385(20):425-433.
29. Drevets D.A., Leenen P.S. The leucocyte facilitated entry of intracellular pathogens into the central nervous system. Microbes Infect 2000, 2:1609-1618.
30. Couderc T.F., Chretien C., Schilte O., Disson O., Brigitte M., Guivel -Benhasine F., et al. A mouse model for Chikungunya: young age and inefficient type-I interferon. Plos Pathog 2008, 4e: 29.
31. Ziegler S.A., Lu L., daRosa A.P., Xiao S.Y., Tesh R.B. An animal model for studying the pathogenesis of Chikungunya virus infection. Am J Trop Med Hyg 2008, 79:133-139.
32. Das T., Jaffaar -Bandjee M.C., Hoarau J.J., Krejbich- Totot P., Denizot M., Lee Pat Yeun G., et al. Chikungunya fever: CNS infection pathologies of a re emerging arbovirus. Prog Neurobiol 2010, 91:121-129.
33. Schwartz O.M., Albert A. Biology and pathogenesis of chickungunya virus. Nat Rev Microbiol 2010, 8:491-500.
34. Schnell M.J., McGettigan J.P., Wirblich C. The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol 2010, 8:51-61.
35. Jackson A.C. Rabies virus infection; an update. J Neurovirol 2003, 9:253-258.
36. Charles P.C., Walters E., Margolis F., Johnston R.E. Mechanisms of neuroinvasion of Venezuelan equine encephalitis in the mouse. J Virol 1995, 208:662-671.
37. Geraghty R.J., Kummenacher C., Cohen G.H., Eisenberg R.J., Spear P.G. Entry of alpha herpes virus mediated by poliovirus receptor related protein1 and poliovirus receptor. Science 1998, 280:1618-1628.
38. Raux H., Flamand A., Blondel D. Interaction of the Rabies virus P protein with the LC8 dynein light chain. J Virol 2000, 74:10212-10216.
39. Tan G.S., Preuss M.A., Williams J.C. The dynein light chain 8 binding motif of rabies phosphoprotein promotes efficient viral transcription. Proc Natl Acad Sci USA 2007, 104:7229-7234.
40. Dimmock N.J., Easton A.J., Leppard K. Introduction to modern virology 2007, 3645-3647. Blackwell. N.J. Dimmock, A.J. Easton, K. Leppard (Eds.).
41. Yao L., Korteweg C., Hsueh W., Gu J. Avian influenza receptor expression in H5N1 - infected and non infected human tissues. FASEB 2008, 22:733-740.
42. Park C.H., Ishinaka M., Takada A., Kida H., Kimura T., Ociai K., et al. The invasion routes of neurovirulent A/Hong Kong H5N1 influenza virus into the central nervous system after respiratory infection in mice. Arch Virol 2002, 147:1425.
43. Gu J., Xie Z., Gao Z., Liu J., Korteweg C., Ye J., et al. H5N1 infection of the respiratory tract and beyond. Lancet 2007, 370:1137-1145.
44. Kortweg C., Gu J. Pathology, molecular biology and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 2008, 172:1155-1170.
45. Diamond M. Virus and host determinants of West Nile virus. PloS pathogens 2009, 5(6). e1000452.
46. Wang T., Town T., Alexopoulou A., Anderson J.F., Fikirg E., Flavel R.A., et al. Toll-like receptor 3 mediates West Nile entry into the brain causing lethal encephalitis. Nat Med 2004, 10:1366-1373.
47. Daffis S., Samuel M., Suthar S., Gale M., Diamond M.S. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 2008, 82:10349-10358.
48. Town T., Bai F., Wang T., Kaplan A.T., Qian F., Montgomery R.R., et al. Toll -like receptor 7 mitigates lethal West Nile encephalitis via interleukin23-dependent immune cell infiltration and homing. Immunity 2009, 20:242-325.
49. Christensen J.E., Lemos C., Moos T., Christensen J.P., Thomsen A.R. CXCL10 is the key ligand for CXCR3 on CD8+effector T cells involved in immune surveillance of the lymphocytic chorion meningitis virus infected nervous system. J Immunol 2006, 176:4235-4243.
50. Muller M., Carter S., Hofert M.J., Campbell I.L. Review: the chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity - a tail of conflict and conundrum. Neuropath Appl Neurobiol 2010, 36:368-387.
51. Garcia-Lopez M.A., Sanchez-Madrid F., Rodriguez-Frade J.M., et al. CXCR3 chemokine receptor distribution in normal and inflamed tissues; expression on activated lymphocytes, endothelial cells dendritic cells. Lab Invest 2001, 81:409-418.
52. Zhang B., Chang Y.K., Lu B., Diamond M.S., Klein R.S. CXCR3 mediates regional -specific antiviral T cell trafficking within central nervous system during West Nile virus encephalitis. J Immunol 2008, 180:2641-2649.
53. McCandless E., Zhang B., Diamond M.S. Klein RS CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile encephalitis. PNAS 2008, 105(32):11270-11275.
54. King J.C., Kesson A.M. Interaction of Flavi viruses with cells of the vertebrate host and decoy of the immune response. Immunol and Cell Biol 2003, 81:207-216.
55. Viver E., Romange F. Good news, bad news for missing -self recognition by NK cells: autoimmune control but viral evasion. Immunity 2007, 26:549-551.
56. Liu Y., King N.J.C., Kesson A., Blanden R.V., Mullbacher A. Flavivirus infection upregulates the expression of Class I and class II Major histocompatibility antigens and enhances T cell recognition of astrocytes in vitro. J Neuroimmunol 1989, 21:157-168.
57. Abraham S., Manjunath R. Induction of classical and non classical MHC-1 on mouse brain astrocytes by Japanese encephalitis virus. Virus Res 2006, 119:216-220.
58. Thongtan T., Ceepsunthorn P., Chaiworkaul V., Rattanrungsan C., Wikan N., Smith D.R., et al. Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir. Microbes Infect 2010, 12(1):137-145.
59. Warfield K.L., Perkins J.G., Swenson D.L., Deal E.M., Bosio C.M., Aman M.J., et al. Role of natural killer cells in innate protection against lethal Ebola virus infection. J Exp Med 2004, 22(2):169-179.
60. Francica J.R., Varela -Rohena A., Medvec A., Plesa G., Riley J.L., Bates P. Steric shielding of surface epitopes and impaired immune recognition by Ebola virus glycoprotein. PLOs Path 2010, 6(9). e1001098.
61. Mohamadzadeh M., Chen L., Schmaljohn A.L. How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007, 7:556-567.
62. Segal B. The role of natural killer cells curbing neuro inflammation. J Neuroimmunol 2007, 191:2-7. review.
63. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease - a double-edged sword. Neuron 2002, 35:419-432.
64. Mukohpadhyay S., Gordon S. The role of scavenger receptors in pathogen recognition and innate immunity. Immunobiology 2009, 209:39-49.
65. Takeuchi, O., and S.Akira. Pattern recognition receptors and inflammation. Cell. 140:805-820.
66. Medzhitov R., Janeway C.A. Innate immune recognition mechanisms and pathways. Immuno Rev 2000, 173:89-97.
67. Iwasski A., Medzhitov R. Regulation of adaptive immunity by the innate system Science 2010, 327:291-295.
68. Griffiths M.R., Gasque P., Neal J.W. The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J Neuropathol Exp Neurol 2009, 68:217-226.
69. Tenner A.J. Membrane receptors for soluble defence collagens. Curr Opin Immunol 1999, 11:34-41.
70. Thieles N.M., Tacnet -Delome P., Arlaud G.J. Interaction of C1q and mannan -binding lectin with viruses. Immunobiology 2002, 205(4-5):563-574.
71. Wagner S., Lynch N.J., Walter W. Differential expression of murine mannose binding lectins A and C in lymphoid and nonlymphoid organs and tissue. J Immunol 2003, 170:1462-1465.
72. Cambi A., Koopman M., Figdorow C.G. C type lectins detect pathogens. Cellular Microbiol 2005, 7(4):481-488.
73. Ji- X., Olinger G., Aris S., Chen Y., Gewurz H., Spear G.T. Mannose binding lectin binds to Ebola and Marburg envelope glycoproteins resulting in blocking of virus interaction with DC-SIGN and complement - mediated virus neutralization. J Gen Virol 2005, 86:2535-2542.
74. Michelow I.C., Dong M., Mungal B.A., Yantosca L.M., Lear C., Ji X., et al. A novel L-ficolin/mannose - binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem 2010, 285(32):24729-24739.
75. Matsuhita M Ficolins: complement- activating lectins involved in innate immunity. J Innate Immunol 2010, 2:24-32.
76. Le Cabec V., Emorine L.J., Toesca I., Cououle C., Maridonneau -Parini I. The human macrophage mannose receptor is not a professional phagocytic receptor. J Leuko Biol 2005, 77:934-943.
77. van Kooyk T., Geijenbeek B.H. DC-SIGN escape mechanism for pathogens. Nat Rev Immunol 2003, 3:697-709.
78. Linehan S.A., M.-P.L., Stahl P.D., Gordon S. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells. J Exp Med 1999, 189:1961-1972.
79. Burudi E.M., Stahl S.R., Riegnier-Vigouroux A. Identification and functional characterisation of the mannose recepot on astrocytes. Glia 1999, 25:44-55.
80. Mukhtar M., Harley S., Chen P., Bou Hamdan M., Patel C., Acheampong E., et al. Primary isolated human brain micro vascular endothelial cells express diverse HIV/SIV associated chemokine co receptors and DC-SGN and L-SIGN. Virology 2002, 297(1):78-88.
81. Schwartz A.J., Alvarez X., Lackner A.A. Distribution and immunophenotype of DC-SIGN -expressing cells in SIV infected and uninfected macaques. AIDS Research Hum Retroviruses 2002, 18(14):1021-1029.
82. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 2005, 11:328-334.
83. Lee B., Soileaux B., Eb O., Doherty U., Baik S., Levroney E., Flummerfelt K., et al. cis expression of DC-SIGN allows for more efficient entry of human and simian immuno deficiency viruses via the CD4 and co receptor. J Virol 2001, 24:12028-12038.
84. Martina B., Koraka P., van den Doel P., Rimmelzwaan G.F., Haagmans B.L., Osterhaus A.D., et al. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN - alpha and TNF -alpha. Virus Res 2008, 135:64-71.
85. Miller J.L., deWet B.J., Martinez -Pomares L., Radcliffe C., Dwek P.M., Gordon S.M. The mannose receptors mediates dengue virus infection of macrophages. Plos Pathog 2008, 4(3). 10.1371.
86. Alvarez C., Lasala F., Carrillo J., Muniz O., Corbi A.L., Delgado R. Type lectins DC In-SIGN and L-SIGN mediate cellular entry Ebola virus in cis and trans. J Virol 2002, 76(13):6841-6844.
87. Upham J.P., Pickett D., Anders T., Reading C. Macrophage receptors for influenza A virus: role for the macrophage galactose-type lectin and mannose receptor in viral entry. J Virol 2010, 84(3):3730-3737.
88. Aronja A., Ledizet M., Anthony K., Bonafe N., Modis Y., Town T., et al. West Nile virus envelope protein inhibits ds RNA- induced innate immune response. J Immunol 2007, 12:8403-8409.
89. Mondotte J.A., Lozach P.Y., Amara A., Gamarnik A.V. Essential role of Dengue virus envelope protein N glycosylation at asparagine -67 during viral replication. J Virol 2007, 81(13):7136-7148.
90. Simmons G., Reeves J.D., Grogan C.C., Vandenberghe L.H., Baribaud F., Whitbeck J.C., et al. DC-SIGN and DC-SIGNR bind Ebola virus glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003, 305:115-123.
91. Zampieri C.A., Sullivan N.J., Nabel G.J. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nature Immunology 2007, 8:1159-1164.
92. Chan S.Y., Empig C.J., Welte F.J., Speck R.F., Schmaljohn A., Kreisberg J.F., et al. Folate receptor α is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 2001, 106:117-126.
93. Takahashi K., Rochford C., Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005, 201:647-657.
94. Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 2009, 15:798-801.
95. Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human P - selectin glycoprotein ligand -1 is a functional receptor for enterovirus 71. Nat Med 2009, 15:794-797.
96. Van Grup H., Delputte P.L., Nauwynck H.J. Scavenger receptor CD163, a jack of all trades and potential target for cell directed therapy. Mo Immunol 2010, 47(7-8):1650-1660.
97. Catanese W.T., Ansuini H., Graziani R., Huby T., Moreau M., Ball J.K., et al. Role of scavenger receptor class B type 1 in hepatitis C virus entry: kinetics and molecular determinants. J Virol 2010, 84(1):43.
98. Husemann J., Loike J.D., Anankov R., Febbrai M., Siverstein S.C., et al. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 2002, 40:195-205.
99. Kawai T., Akira S. The role of pattern -recognition receptors in innate immunity; update on Toll like receptors. Nat Immunol 2010, 11:373-384.
100. Ting J.P.Y., Duncan J.A., Lei Y. How the inflammasome NLRs function in the innate immune system. Science 2010, 327:286-290.
101. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
102. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002, 61:1013-1019.
103. Iliev A.I., Stringaris A.K., Nau R., Neumann H. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). Faseb J 2004, 18:412-414.
104. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004, 173:3916-3924.
105. Prehaud C., Megret F., Lafage M., Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 2005, 79:12893-12904.
106. Jack C.S., Arbour N., Manusow J., Montagrain M., Blain M., McCrea E., et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005, 175:4320-4330.
107. Farina C., Krumbholz M., Giese T. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol 2005, 159:12-19.
108. Bsibsi M., Persoon-Deen C., Verwer R.W., Meesuswen S., Ravid R., van Noort J.M. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 2006, 53:688-695.
109. Jackson A.C., Rossiter J.P., Lafon M. Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J Neurovirol 2006, 12:229-234.
110. Carpentier P.A., Williams B.R., Mille R. Distinct roles of protein kinase R and toll-like receptor 3 in of astrocytes by viral stimuli. Glia 2007, 55:239-252.
111. Suh H.S., Brosnan C.F., Lee S.C. Toll like receptors in CNS viral infections. Current Topic Microbiol Immunol 2009, 336:63-81.
112. Hoarau J.J., Krejbich -Trotot P., Jaffar-Bandjee M.C., Das T., Thon -Hon V., Neal J.W., et al. Activation and control of the CNS innate immune response in health and disease; a balancing act finely tuned by neuroimmune regulators. CNS & Neurol Disord Drug Targets 2011, 1(10):25-43.
113. Wagner E.K., Hewlett M.J., Bloom D.C., Camerini D. Basic virology, Chapter 8, strategies to protect against and combat viral infection 2008, Blackwell Publishing, pp. 120-142.
114. Paul S.C., Ricour C., Sommereyns F., Sorgeloos F., Michiels T. Type I interferon response in the central nervous system. Biochimie 2007, 89:770-778.
115. Chattopadhyay S., Marques J.T., Yamashita M., Peters K.L., Smith K., Desai A., et al. Viral apoptosis is induced by IRF-3 mediated activation of Bax. EMBO 2010, 29(10):1762-1773.
116. LeGoffic R., Potchlichet J., Vitour D., Fujita T., Meurs E., Chgnard M., et al. Cutting edge: influenza A virus activates TLR-3dependent inflammatory and RIG-I-dependent inflammatory and RIG-1 -dependent antiviral response in human lung epithelial cells. J Immunol 2007, 187:3368-3372.
117. Koyama S., Ishi K.J., Kumar H., Tanimoto T., Coban C., Uematsu S., et al. Differential role of TLR-and RLR signalling in the immune response to influenza A virus infection and vaccination. J Immunol 2007, 179(7):4711-4720.
118. De Miranda J., Yaddanapudi K., Hornig M., Lipkin W.I. Astrocytes recognize intracellular polyinosinic -polycytidylic acid via MDA-5. Faseb J 2009, 23:1064-1071.
119. Fujita T., Onoguchi K., Onomoto R., Hirai R., Yoneymai M. Triggering antiviral response by RIG-I-related RNA helicases. Biochimie 2007, 89:754-760.
120. Furr S.R., Chauhan V.S., Sterka D., Grdzelishvilli V., Marriot I. Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus. J Neurovirol 2008, 1-11.
121. Frederickersen B.L., Keller B.C., Forneck J., Katze M.G., Gale M. Establishment and maintenance of the innate antiviral response to West Nile Fever involves both RIG-1and MDA5 signalling through IPS-1. J Virol 2008, 82:609-616.
122. Nazmi A., Dutta K., Basu A. RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis infection. PLos One 2011, 6:e21761.
123. Wang P., Aronja A., Zhang Y., Sultana H., Dai J., Yiang L., et al. Caspase -12 controls West Nile virus infection via the viral RNA receptors RIG-1. Nat Immunol 2010, 10:912-919.
124. Faul K.J., Wanjalla C.N., Suthar M.S., Gale M., Wirbilch C., Schnell M.J., et al. Rabies virus infection induces type 1 interferon production in an IPS -1 dependent manner while dendritic cell activation relies on IFNAR signalling. PLoS Path 2010, 6(7). e10001016.
125. Suthar M.S., Ma D.Y., Thomas S., Lund J.M., Zhang N., Daffis S., et al. IPS-1 is essential for the control of West Nile virus infection and immunity. PloS Pathog 2010, 6. e1000757.
126. Clarke P., Tyler K. Apoptosis in animal models of virus -induced disease. Nature Rev Microbiology 2009, 7:144-155.
127. Benedict C.A., Norris P., Ware C.F. To kill or be killed: viral evasion of apoptosis. Nature Immunology 2002, 3(11):1013-1018.
128. Choi C., Benveniste E. Fas ligand/fas system in the brain; regulator of immune and apoptotic response. Brain Res Brain Res Rev 2004, 4:65-81.
129. Prehaud C., Lay S., Dietzschold B. Glycoprotein of the of non pathogenic rabies viruses is a key determinant of human cell apoptosis. J Virol 2003, 77:10537-10547.
130. Baloul L., Camelo S., Lafon M. Up-regulation of Fas ligand (FASL) in the central nervous system: a mechanism of immune evasion by rabies virus. J Neurovirol 2004, 10(6):372-382.
131. Jang H., Boltz D., Strum-Ramierz K., Shepard K.R., Jiao Y., Webster R., et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Sci USA 2009, 106(33):14063-14068.
132. Rimmelzwaan G.F., Kuiken T., van Amerongen G., Bestebroer T.M., Fouchier R.A., Osterhaus A.D., et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 2001, 75:6687-6691.
133. Lafone M., Megret F., Meuth S.G. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. J Immunol 2008, 180:7506-7515.
134. Savill J., Dransfield I., Gregory C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002, 2:965-975.
135. Gregory C. CD14 dependent clearance of apoptotic cells: relevance to the immune system. Curr Opin in Immunol 2000, 12:27-43.
136. Elward K.P., Gasque P. Eat me and don't eat me signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. Mol Immunol 2003, 40:85-94.
137. Gardai S., Bratton D.L., Ogden C.A., Henson P.M. Recognition ligands on apoptotic cells; a perspective. J Leukco Biol 2006, 79:896-903.
138. Katze M.G., He Y., Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002, 2:675-687.
139. Goodbourn S., Didcock L., Randall R.E. Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. Journ Gen Virol 2000, 81:2341-2364.
140. George C.X., Li Z., Okonski K.M., Toth A.M., Wang Y., Samuel C.E. Tipping the balance; antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products. J Interferon Cytokine Res 2009, 9:477-487.
141. Toth A.M., Li Z., Cattaneo R., Samuel C.E. RNA - specific adenosine deaminase ADAR1 suppresses measles virus - induced apoptosis and activation of kinase PKR. J Biol Chem 2009, 284(43):29350-29356.
142. Chang T.H., Liao C.L., Yin Y.L. Flavirus induces interferon -beta gene expresiion through a pathway involving RIG-I-dependent IRF-3 and PI3K -dependent NF-kappa B activation. Micro Infection 2006, 1:157-171.
143. Lin R.J., Liao C.L., Lin E. Blocking of the alpha interferon-induced Jak-stat signaling pathway by Japanese encephalitis virus infection. J Virol 2004, 78:9285-9294.
144. Brehin A.C., Casademont I., Frenkiel M.P., Julier C., Sakuntabhai A., DespresP, et al. The large form of the human 2',5'-oligoadenylate synthetase (OAS3) exerts antiviral effects against Chickungunya virus. Virology 2009, 384:216-222.
145. Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., et al. The 3C protein of the entero virus 71 inhibits retinoid acid inducible gene I - mediated interferon regulatory factor3 activation and type 1 interferon responses. J Virol 2010, 16:8051-8061.
146. Zheng Z., Li H., Zhang Z., Meng J., Mao D., Bai B., et al. Enterovirus 712C protein inhibits TNFa- mediated activation of NF-kB by suppressing IkBkinase phosphorylation. J Immunol 2011, 187:2202-2212.
147. Chen T.-S., Lai Y.K., Yun C.K., Juang J.L. Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell Microbiol 2007, 9:2676-2688.
148. Kochs G., Garcia- Matinez-Sobrido L., A-Sastre Garcia A multiple anti -interferon actions of the influenza virus NS1 protein. J Virol 2007, 13:7011-7021.
149. Mibayashi M., Matinez-Sobrido L., Loo Y.M., Cardenas W.B., Gale M., Garcia -Sastre A., et al. Inhibiton of retinoic acid -inducible gene 1-mediated induction of beta interferon by the NS1protein of influenza A virus. J Virol 2007, 2:514-524.
150. Hale B.G., Randall R.E., Ortin J., Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008, 89:2359-2376.
151. Ehrhardt C., Wolff T., Pleschka O., Planz O., Beerman W., Bode J.G., et al. Influenza A virus NS1protein activates the PI3K/Akt pathway to mediate antiapoptotic signalling responses. J Virol 2007, 7:3058-3067.
152. Basler C.F., Aguilar P. Progress in identifying virulence determinants of the 1918H1N1 and south east Asian H5N1 influenza A viruses. Anti viral Res 2008, 79(3):166-178.
153. Parisien J.P., Bamming D., Komuo A., Ramachandran A., Rodriguez J.J., Barber G., et al. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J Virol 2009, 14:7252-7260.
154. Ebar S., Diederich S., Maisner A. Selective receptor expression restricts Nipah virus infection of endothelial cells. Virol J 2008, 25(5):142.
155. Cardenas W.B., Loo Y.M., Gale Mjr, Hartman A.L., Kimberlin C.R., Martinez-Sobrido L., et al. Ebola virus VP35protein binds double stranded RNA and inhibits α/β interferon production induced by RIG -1 signalling. J Virol 2006, 80:5168-5178.
156. Basler C.F., Amarasinghe G.K. Evasion of interferon responses by Ebola and Marburg viruses. J Interferon Cytokine Res 2009, 29(9):511-520.
157. Bosiso C.M., Aman M.J., Grogan C., Hogan R., Ruthel G., Negley D., et al. Ebola and Marburgh viruses replicate in monocyte -derived dendritic cells without inducing production of cytokines and full maturation. J Infect Disease 2003, 188:1630-1638.
158. Bai F., Town T., Pradhan D., Cox J., Ashish, Ledizet M., et al. Antiviral peptides targeting the West Nile virus envelope protein. J Virol 2007, 81:2047-2055.
159. Root M.J., Steger H.K. HIV- gp41 as a target for viral entry inhibition. Curr Pharm Des 2004, 10:1805-1825.
160. Tan F.L., Yin J.Q. RNAi, a new therapeutic strategy against viral infection. Cell Research 2004, 14:460-466.
161. Castanotto D.J., Rossi J. The promises and pitfalls of RNA- interfernce -based therapeutics. Nature 2009, 457:426-433.
162. Ong S.P., Choo B.G.H., Chu J.H., Ng M.L. Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication. Anti Virus Research 2006, 72:3216-3233.
163. Geiss B.J., Pierson T.C., Diamond M.S. Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA. Virol J 2005, 2:53.
164. Kumar P., Lee S.K., Shankar P., Manuath N. A single si RNA supresses fatal encephalitis induced by T two different Flavi viruses. PLOS med 2006, 3(4):e96.
165. Mungall B.A., Schopman N.C.T., Lambet L.S. Inhibiton of Henipavirus infection by RNA interference. Anti Virus research 2008, 80:324-331.
166. Gupta P.K., Sonwane A.A., Sihgh N.K., Mesharm C.D., Dahiya S.S., Pawar S.S., et al. Intracerebral delivery of small interfering RNAs (siRNA) using adenoviral vectors protects mice against peripheral rabies challenge. Virus Research 2001, 16.
167. Kumar P., Wu H., McBride J.L., Jung K.E., Kim M.H., Davidson B.L., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448:39-43.
168. Kim S.S., Ye C., Kumar P., Chiu I., Subramanya S., Wu H., et al. Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Molecular Therapy 2010, 18:993-1001.